CAS RN: 209216-23-9
Entecavir Monohydrate
Product Availability
Choose a grade to view its available package options.
15 package records15 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20260404 |
10mg |
In stock |
| Inquiry |
| Batchno.20250625 |
1g |
In stock |
| Inquiry |
| Batchno.20260307 |
250mg |
In stock |
| Inquiry |
| Batchno.20251120 |
50mg |
In stock |
| Inquiry |
| Batchno.20260312 |
5g |
In stock |
| Inquiry |
| Batchno.20251106 |
5mg |
In stock |
| Inquiry |
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20260129 |
100mg |
In stock |
Shanghai, Wuhan, Chengdu | Inquiry |
| Batchno.20251223 |
10g |
In stock |
Shanghai | Inquiry |
| Batchno.20250314 |
10mg |
In stock |
Shanghai | Inquiry |
| Batchno.20250103 |
1g |
In stock |
Shanghai, Tianjin, Wuhan, Chengdu | Inquiry |
| Batchno.20250313 |
1mg |
In stock |
Shanghai | Inquiry |
| Batchno.20250124 |
250mg |
In stock |
Shanghai, Shenzhen, Tianjin, Wuhan, Chengdu | Inquiry |
| Batchno.20260125 |
50mg |
In stock |
Shanghai | Inquiry |
| Batchno.20250821 |
5g |
In stock |
Shanghai, Shenzhen | Inquiry |
| Batchno.20250530 |
5mg |
In stock |
Shanghai | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.25g, 0.1g
- Available purity: ≥98%
- Inventory rows with stock: 1
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 209216-23-9
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.25g |
≥98% |
1
In Stock
|
Shanghai |
Inquiry |
| 0.1g |
≥98% |
0
Out of Stock
|
Shenzhen |
Inquiry |
209216-23-9 / 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1H-purin-6-one;hydrate
Standard CAS: 209216-23-9
Multi CAS: No
Basic Information
CAS
209216-23-9
Multi CAS
No
Molecular Formula
C12H17N5O4
Molecular Weight
295.290000
Exact Mass
295.128054
SMILES
C=C1[C@H](C[C@@H]([C@H]1CO)O)N2C=NC3=C2N=C(NC3=O)N.O
InChI
InChI=1S/C12H15N5O3.H2O/c1-5-6(3-18)8(19)2-7(5)17-4-14-9-10(17)15-12(13)16-11(9)20;/h4,6-8,18-19H,1-3H2,(H3,13,15,16,20);1H2/t6-,7-,8-;/m0./s1
InChIKey
YXPVEXCTPGULBZ-WQYNNSOESA-N
Computed Properties
Structural Parameters
Heavy atom count
21
Aromatic heavy atom count
9
Fraction Csp3
0.42
Rotatable bonds
2
H-bond acceptors
7
H-bond donors
4
Molar refractivity
75.55
TPSA
161.55
LogP / Solubility
WLOGP
-1.65
MLOGP
-1.44
XLogP3
-1.65
Consensus LogP
-1.58
Log S (ESOL)
-0.81
Class (ESOL)
Very soluble
Log S (Ali)
-0.79
Class (Ali)
Very soluble
Log S (SILICOS-IT)
-0.45
Class (SILICOS-IT)
Very soluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-5.69
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
Yes
Synthetic Accessibility
4